Publication Name	World Journal of Diabetes
Manuscript ID	96288
Country	China

Received	2024-05-02 06:20
Peer-Review Started	2024-05-02 06:21
To Make the First Decision
Return for Revision	2024-05-18 16:43
Revised	2024-06-05 08:22
Second Decision	2024-06-28 02:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-28 08:15
Articles in Press	2024-06-28 08:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-15 02:22
Publish the Manuscript Online	2024-07-26 06:56

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Letter to the Editor
Article Title	Vitamin D and selenium for type 2 diabetes mellitus with Hashimoto’s thyroiditis: Dosage and duration insights
Manuscript Source	Invited Manuscript
All Author List	Yun-Feng Yu, Xue-Li Shangguan, Dan-Ni Tan, Li-Na Qin and Rong Yu
ORCID	Author(s) ORCID Number Yun-Feng Yu http://orcid.org/0000-0002-7309-5608 Xue-Li Shangguan http://orcid.org/0009-0003-7108-3560 Rong Yu http://orcid.org/0009-0005-0840-2797
Funding Agency and Grant Number	Funding Agency Grant Number Discipline Construction Project of Hunan University of Chinese Medicine 22JBZ002
Corresponding Author	Rong Yu, MD, PhD, Full Professor, School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, No. 300 Xueshi Road, Hanpu Science and Education Park, Yuelu District, Changsha 410208, Hunan Province, China. yurong196905@163.com
Key Words	Vitamin D; Selenium; Type 2 diabetes mellitus; Hashimoto’s thyroiditis; Dosage; Duration
Core Tip	Supplementation with vitamin D and selenium shows promise in improving the prognosis of type 2 diabetes mellitus (T2DM) and Hashimoto's thyroiditis (HT). Despite controversies surrounding their efficacy, a retrospective study discussed in this letter reveals significant benefits from adding these supplements to antidiabetic regimens. Based on this research and current literature, we recommend a regimen of 4000 IU/day of vitamin D and 100-200 μg/day of selenium for over three to six months for patients with HT, particularly for those with concurrent T2DM.
Publish Date	2024-07-26 06:56
Citation	<p>Yu YF, Shangguan XL, Tan DN, Qin LN, Yu R. Vitamin D and selenium for type 2 diabetes mellitus with Hashimoto’s thyroiditis: Dosage and duration insights. <i>World J Diabetes</i> 2024; 15(8): 1824-1828</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i8/1824.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i8.1824

Full Article (PDF)	WJD-15-1824-with-cover.pdf
Manuscript File	96288_Auto_Edited-YJP.docx
Answering Reviewers	96288-answering-reviewers.pdf
Audio Core Tip	96288-audio.mp3
Conflict-of-Interest Disclosure Form	96288-conflict-of-interest-statement.pdf
Copyright License Agreement	96288-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	96288-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	96288-non-native-speakers.pdf
Peer-review Report	96288-peer-reviews.pdf
Scientific Misconduct Check	96288-scientific-misconduct-check.png
Scientific Editor Work List	96288-scientific-editor-work-list.pdf
CrossCheck Report	96288-crosscheck-report.png
CrossCheck Report	96288-crosscheck-report.pdf